Praxis Precision Medicines attracts $110m
Cambridge, Massachusetts-based Praxis Precision Medicines, a biopharmaceutical company, has raised $110 million in Series C1 financing.
Cambridge, Massachusetts-based Praxis Precision Medicines, a biopharmaceutical company, has raised $110 million in Series C1 financing.
Copyright PEI Media
Not for publication, email or dissemination